Bitdeer Technologies
BTDR
BIT Mining
BTCM
Digihost Technology
DGHI
The9 Ltd
NCTY
Canaan
CAN
US Stock MarketDetailed Quotes
MGNX Macrogenics
- 2.520
- -0.020-0.79%
Trading Feb 26 09:38 ET
158.16MMarket Cap-1.61P/E (TTM)
2.630High2.520Low12.00KVolume2.540Open2.540Pre Close30.63KTurnover0.02%Turnover RatioLossP/E (Static)62.76MShares21.88052wk High1.32P/B131.07MFloat Cap2.34052wk Low--Dividend TTM52.01MShs Float41.000Historical High--Div YieldTTM4.33%Amplitude2.130Historical Low2.552Avg Price1Lot Size
About Macrogenics Company
MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.
Company Profile
SymbolMGNX
Company NameMacrogenics
Listing DateOct 10, 2013
Issue Price16.00
Founded2000
CEODr. Scott Koenig, M.D.,PhD
MarketNASDAQ
Employees339
Fiscal Year Ends12-31
Address9704 Medical Center Drive
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850-3368
Phone1-301-251-5172
Websitehttp://www.macrogenics.com
Company Executives
- Name
- Position
- Salary
- Dr. Scott Koenig, M.D.,PhD
- Director, President and Chief Executive Officer
- 3.71M
- Dr. Ezio Bonvini, M.D.
- Senior Vice President, Research and Chief Scientific Officer
- --
- Eric Risser
- Chief Operating Officer
- --
- Dr. Stephen L. Eck
- Senior Vice President, Clinical Development and Chief Medical Officer
- 1.75M
- James Karrels
- Senior Vice President, Chief Financial Officer and Corporate Secretary
- 1.58M
- Jeffrey Stuart Peters
- Senior Vice President, General Counsel and Corporate Compliance Officer
- --
- Beth Smith
- Vice President, Controller, Treasurer and Principal Accounting Officer
- --
- Thomas Spitznagel
- Senior Vice President, Technical Operations
- --
- William K. Heiden
- Chairman of the Board
- 180.13K
- Dr. Karen Jean Ferrante, M.D.
- Independent Director
- 135.75K
- Federica O'Brien
- Independent Director
- 152.00K
- Scott T. Jackson, M.B.A.
- Independent Director
- 167.63K
- Dr. David C. Stump,M.D.
- Independent Director
- 160.75K
- Meenu Chhabra Karson
- Independent Director
- 335.41K
- Edward M. Hurwitz, J.D.
- Independent Director
- 147.63K
- Dr. Margaret A. Liu, M.D.
- Independent Director
- 318.32K
- Dr. Jay Siegel, M.D.
- Independent Director
- 167.21K
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.